Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2020 Filed Feb 20, 2020 22:40 UTC |
IPPOLITO PETER J.President, The Americas Group
|
Tax withholdingCommon Stock | 644 | $580.04 | $373,545.76 |
DisclosureSEC source: 0001209191-20-011226 · doc4.xml · nonDerivative · entry 2 IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,332 F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:40 UTC |
IPPOLITO PETER J.President, The Americas Group
|
GrantCommon Stock | 1,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011226 · doc4.xml · nonDerivative · entry 1 IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,976 F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:36 UTC |
GARCEAU MARY LSVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 234 | $580.04 | $135,729.36 |
DisclosureSEC source: 0001209191-20-011223 · doc4.xml · nonDerivative · entry 2 GARCEAU MARY L · CIK 0001368800 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,569 F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:36 UTC |
GARCEAU MARY LSVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011223 · doc4.xml · nonDerivative · entry 1 GARCEAU MARY L · CIK 0001368800 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,803 F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:34 UTC |
CRONIN JANE M.SVP - Corporate Controller
|
Tax withholdingCommon Stock | 409 | $580.04 | $237,236.36 |
DisclosureSEC source: 0001209191-20-011221 · doc4.xml · nonDerivative · entry 2 CRONIN JANE M. · CIK 0001688222 · SVP - Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,823 F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:34 UTC |
CRONIN JANE M.SVP - Corporate Controller
|
GrantCommon Stock | 1,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011221 · doc4.xml · nonDerivative · entry 1 CRONIN JANE M. · CIK 0001688222 · SVP - Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,232 F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:32 UTC |
Baxter Joel D.Pres. & GM, Glob. Supply Chain
|
Tax withholdingCommon Stock | 1,141 | $580.04 | $661,825.64 |
DisclosureSEC source: 0001209191-20-011217 · doc4.xml · nonDerivative · entry 2 Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,435 F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units. F3 · balance_after: Of shares listed, 1,277 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:32 UTC |
Baxter Joel D.Pres. & GM, Glob. Supply Chain
|
GrantCommon Stock | 3,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011217 · doc4.xml · nonDerivative · entry 1 Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,576 F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 16:05 UTC |
THAMAN MICHAEL HDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010932 · doc4.xml · nonDerivative · entry 1 THAMAN MICHAEL H · CIK 0001228309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 824 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 16:07 UTC |
Thornton Matthew IIIDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010933 · doc4.xml · nonDerivative · entry 1 Thornton Matthew III · CIK 0001611473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,094 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 669 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 16:01 UTC |
KROPF SUSAN JDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010930 · doc4.xml · nonDerivative · entry 1 KROPF SUSAN J · CIK 0001051402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,816 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 669 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 15:58 UTC |
KRAMER RICHARD JDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010929 · doc4.xml · nonDerivative · entry 1 KRAMER RICHARD J · CIK 0001201067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,581 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 669 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 15:56 UTC |
Hodnik David FDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010928 · doc4.xml · nonDerivative · entry 1 Hodnik David F · CIK 0001333169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of the shares listed, 669 are restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 15:51 UTC |
FETTIG JEFF MDirector
|
GrantCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010927 · doc4.xml · nonDerivative · entry 1 FETTIG JEFF M · CIK 0001224295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 649 are restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,733 | $0.00 Strike: $239.55 | $0.00 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · derivative · entry 8 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,733 shares Expires 2025-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 400 | $574.60 | $229,840.00 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 6 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,386 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.45 to $574.85 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 1,639 | $573.62 | $940,163.18 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 5 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,786 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.23 to $574.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 5,512 | $572.71 | $3,156,777.52 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 4 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,425 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.23 to $573.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 5,839 | $571.77 | $3,338,565.03 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 3 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,937 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.25 to $572.19 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 1,343 | $570.87 | $766,678.41 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 2 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,776 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.23 to $571.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:54 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 14,733 | $239.55 | $3,529,290.15 |
DisclosureSEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 1 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:30 UTC |
Anton Arthur FDirector
|
GiftCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006462 · doc4.xml · nonDerivative · entry 1 Anton Arthur F · CIK 0001358902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,284 F1 · balance_after: Of shares listed, 828 are restricted stock units. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 14:17 UTC |
Jaye James RSVP - IR & Corp. Comm.
|
GrantPhantom Stock Units · Derivative | 0.34 | $594.84 | $202.25 |
DisclosureSEC source: 0001209191-20-005077 · doc4.xml · derivative · entry 1 Jaye James R · CIK 0001777298 · SVP - IR & Corp. Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0.7 Underlying: Common Stock · 0.34 shares Expires not disclosed F1 · derivative.exercise_price: Represents the number of phantom stock units that were acquired by the reporting person (in an exempt transaction) under The Sherwin-Williams Company 2005 Key Management Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of common stock and is payable in cash. The phantom stock units have dividend equivalent rights. F2 · derivative.exercise_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service. F2 · derivative.expiration_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 20:16 UTC |
Jaye James RSVP - IR & Corp. Comm.
|
GrantPhantom Stock Units · Derivative | 0.36 | $567.09 | $204.15 |
DisclosureSEC source: 0001209191-20-003274 · doc4.xml · derivative · entry 1 Jaye James R · CIK 0001777298 · SVP - IR & Corp. Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0.36 Underlying: Common Stock · 0.36 shares Expires not disclosed F1 · derivative.exercise_price: Represents the number of phantom stock units that were acquired by the reporting person (in an exempt transaction) under The Sherwin-Williams Company 2005 Key Management Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of common stock and is payable in cash. The phantom stock units have dividend equivalent rights. F2 · derivative.exercise_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service. F2 · derivative.expiration_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:17 UTC |
KROPF SUSAN JDirector
|
GrantPhantom Stock Units · Derivative | 65.15 | $567.91 | $36,999.34 |
DisclosureSEC source: 0001209191-20-002252 · doc4.xml · derivative · entry 1 KROPF SUSAN J · CIK 0001051402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,906.01 Underlying: Common Stock · 65.15 shares Expires not disclosed F1 · derivative.exercise_price: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement. F1 · shares: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement. F1 · derivative.exercise_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement. F1 · derivative.expiration_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement. F2 · balance_after: Includes phantom stock units acquired pursuant to the dividend reinvestment feature of the plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:14 UTC |
WUNNING STEVEN HDirector
|
GrantCommon Stock | 70.43 | $567.91 | $39,997.90 |
DisclosureSEC source: 0001209191-20-002249 · doc4.xml · nonDerivative · entry 1 WUNNING STEVEN H · CIK 0001171788 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 1,805.51 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:11 UTC |
THAMAN MICHAEL HDirector
|
GrantCommon Stock | 55.03 | $567.91 | $31,252.09 |
DisclosureSEC source: 0001209191-20-002243 · doc4.xml · nonDerivative · entry 1 THAMAN MICHAEL H · CIK 0001228309 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 772.92 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 20:56 UTC |
POON CHRISTINE ADirector
|
GrantCommon Stock | 15.96 | $567.91 | $9,063.84 |
DisclosureSEC source: 0001209191-20-002237 · doc4.xml · nonDerivative · entry 1 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 608.14 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 20:53 UTC |
KRAMER RICHARD JDirector
|
GrantCommon Stock | 55.03 | $567.91 | $31,252.09 |
DisclosureSEC source: 0001209191-20-002235 · doc4.xml · nonDerivative · entry 1 KRAMER RICHARD J · CIK 0001201067 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 2,929.22 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 20:50 UTC |
ANDERSON KERRII BDirector
|
GrantCommon Stock | 13.76 | $567.91 | $7,814.44 |
DisclosureSEC source: 0001209191-20-002232 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 44.93 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,734 | $0.00 Strike: $239.55 | $0.00 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · derivative · entry 9 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,734 shares Expires 2025-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 300 | $580.22 | $174,066.00 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 7 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,386 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.04 to $580.51 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 516 | $579.50 | $299,022.00 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 6 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,686 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.04 to $580.01 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 631 | $578.59 | $365,090.29 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 5 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,202 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.00 to $578.69 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 4,820 | $577.40 | $2,783,068.00 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 4 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,833 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.96 to $577.95 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 6,415 | $576.49 | $3,698,183.35 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 3 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,653 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.96 to $576.94 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
SaleCommon Stock | 2,052 | $575.52 | $1,180,967.04 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 2 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,068 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.95 to $575.92 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:45 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 14,734 | $239.55 | $3,529,529.70 |
DisclosureSEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 1 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. Read SEC document |
| December 04, 2019 Filed Jan 7, 2020 19:33 UTC |
Sewell David BPresident and COO
|
GiftCommon Stock | 174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002202 · doc5.xml · nonDerivative · entry 1 Sewell David B · CIK 0001617514 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,721 Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 14:46 UTC |
ERTER AARON MPresident, Perf Coatings Grp
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,380 | $0.00 Strike: $383.92 | $0.00 |
DisclosureSEC source: 0001209191-19-056259 · doc4.xml · derivative · entry 5 ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520 Underlying: Common Stock · 1,380 shares Expires 2027-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 14:46 UTC |
ERTER AARON MPresident, Perf Coatings Grp
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $383.92 | $0.00 |
DisclosureSEC source: 0001209191-19-056259 · doc4.xml · derivative · entry 4 ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires 2027-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 14:46 UTC |
ERTER AARON MPresident, Perf Coatings Grp
|
SaleCommon Stock | 3,280 | $580.62 | $1,904,433.60 |
DisclosureSEC source: 0001209191-19-056259 · doc4.xml · nonDerivative · entry 2 ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,506 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.53 to $580.71 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Of shares listed, 1,597 are restricted stock units. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 14:46 UTC |
ERTER AARON MPresident, Perf Coatings Grp
|
Exercise / conversionCommon Stock | 3,280 | $383.92 | $1,259,257.60 |
DisclosureSEC source: 0001209191-19-056259 · doc4.xml · nonDerivative · entry 1 ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 14:23 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 370 | $0.00 Strike: $270.12 | $0.00 |
DisclosureSEC source: 0001209191-19-054682 · doc4.xml · derivative · entry 3 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,263 Underlying: Common Stock · 370 shares Expires 2026-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 14:23 UTC |
MORIKIS JOHN GDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 370 | $270.12 | $99,944.40 |
DisclosureSEC source: 0001209191-19-054682 · doc4.xml · nonDerivative · entry 1 MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 29, 2019 17:10 UTC |
Baxter Joel D.Pres. & GM, Glob. Supply Chain
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 370 | $0.00 Strike: $270.12 | $0.00 |
DisclosureSEC source: 0001209191-19-054307 · doc4.xml · derivative · entry 3 Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030 Underlying: Common Stock · 370 shares Expires 2026-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 29, 2019 17:10 UTC |
Baxter Joel D.Pres. & GM, Glob. Supply Chain
|
Exercise / conversionCommon Stock | 370 | $270.12 | $99,944.40 |
DisclosureSEC source: 0001209191-19-054307 · doc4.xml · nonDerivative · entry 1 Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Of shares listed, 1,277 are restricted stock units. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 15:01 UTC |
GILLIGAN THOMAS PSVP-Human Resources
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,417 | $0.00 Strike: $78.26 | $0.00 |
DisclosureSEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 6 GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,417 shares Expires 2021-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 15:01 UTC |
GILLIGAN THOMAS PSVP-Human Resources
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,416 | $0.00 Strike: $78.26 | $0.00 |
DisclosureSEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 5 GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,416 shares Expires 2021-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 15:01 UTC |
GILLIGAN THOMAS PSVP-Human Resources
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,417 | $0.00 Strike: $78.26 | $0.00 |
DisclosureSEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 4 GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,417 shares Expires 2021-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.